Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world cohort study of Gulu Bushen pills for nocturia and chronic low back pain in older adults with frailty
ChiCTR2400085372Phase 4Not yet recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of Gulu Bushen pill in Fragility, nocturia and chronic low back pain (CLBP) (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: Change in the number of nocturnal urinations, Change in global pain assessment scale score and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Gulu Bushen pill
03
Conditions
Fragilitynocturiachronic low back pain (CLBP)
Beyond the preview
Go deeper on ChiCTR2400085372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085372.